![Per Wold-Olsen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Per Wold-Olsen
Président chez
ONCOPEPTIDES AB
Fortune : 927 883 $ au 31/05/2026
Profil
Per Wold-Olsen est un homme d'affaires norvégien qui a été à la tête de 8 entreprises différentes. Actuellement, il est président de GN Store Nord A, président de GN Audio A, président de GN Hearing An et président de GN Netcom A (qui sont toutes des filiales de GN Store Nord A) et président d'Oncopeptides AB. Il est également membre du conseil d'administration de Gilead Sciences, Inc. et de Bio Malter et président de MMV Medicines for Malaria Venture. Il a précédemment occupé le poste de président de la division intercontinentale chez Merck & Co., Inc. et de directeur général de MSD (Norge) AS (une filiale de Merck & Co., Inc.), de directeur régional et de vice-président de MSD Scandinavia AS et de président du conseil de surveillance de H. Lundbeck A. Il est titulaire d'un MBA de l'université du Wisconsin et d'un MBA de la BI Norwegian Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SENZIME AB 0,72 % | 23/09/2025 | 1 126 344 ( 0,72 % ) | 605 061 $ | 31/05/2026 |
ONCOPEPTIDES AB 0,42 % | 09/06/2026 | 1 646 802 ( 0,42 % ) | 322 823 $ | 31/05/2026 |
Dernières actualités sur Per Wold-Olsen
Postes actifs de Per Wold-Olsen
| Sociétés | Poste | Début |
|---|---|---|
| ONCOPEPTIDES AB | Président | 17/05/2018 |
| SENZIME AB | Président | 01/11/2023 |
Bio Malter | Directeur/Membre du Conseil | - |
Forepont Capital LLC
 Forepont Capital LLC Investment ManagersFinance Forepont Capital Partners invests in companies located in United States, western Europe, Singapore, Australia, and Israel. The firm focuses on sectors such as biotech, medtech, and e-health. It participates in early-stage transactions. | Directeur/Membre du Conseil | - |
GN Hearing A/S
 GN Hearing A/S Medical SpecialtiesHealth Technology Manufactures hearing-aid devices | Président | 16/06/2008 |
MMV Medicines for Malaria Venture
 MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services Develops antimalarial drugs | Président | - |
Anciens postes connus de Per Wold-Olsen
| Sociétés | Poste | Fin |
|---|---|---|
| GN STORE NORD A/S | Président | 15/03/2023 |
| AMARIN CORPORATION PLC | Président | 28/02/2023 |
| H. LUNDBECK A/S | Président | 30/03/2011 |
| ░░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Per Wold-Olsen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
98
Relations au 1er degré
23
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 23 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Amarin Corp. Plc
 Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
Royal Numico NV
 Royal Numico NV Food: Specialty/CandyConsumer Non-Durables Manufactures baby food and clinical nutrition products | Consumer Non-Durables |
inVentiv Health Clinical, Inc.
 inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research and drug development services | Commercial Services |
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Glyconix Corp.
 Glyconix Corp. Pharmaceuticals: MajorHealth Technology Manufactures anti infective and oncology drugs | Health Technology |
Senzime AB
 Senzime AB Medical SpecialtiesHealth Technology Develops and markets an enzyme based biosensor technology | Health Technology |
GN Store Nord A/S
 GN Store Nord A/S Telecommunications EquipmentElectronic Technology Provides telecommunications and hearing instruments | Electronic Technology |
GN Audio A/S
 GN Audio A/S Electronic Production EquipmentElectronic Technology Develops, manufactures, and markets corded and wireless headsets, amplifiers for headsets, and headset telephones | Electronic Technology |
GN Hearing A/S
GN Hearing A/S Medical SpecialtiesHealth Technology Manufactures hearing-aid devices | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopeptides AB
 Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Exiqon A/S
 Exiqon A/S Miscellaneous Commercial ServicesCommercial Services Engages in the pharmaceutical industry | Commercial Services |
BI Norwegian Business School
 BI Norwegian Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
World Growth | |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services Develops antimalarial drugs | Commercial Services |
PharmaSet SAS
 PharmaSet SAS Medical SpecialtiesHealth Technology Manufactures and distributes disposable healthcare kits for hospital use | Health Technology |
MSD (Norge) AS
 MSD (Norge) AS Pharmaceuticals: MajorHealth Technology Engages in researching, manufacturing and marketing of drugs | Health Technology |
Bio Malter | |
MSD Scandinavia AS | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings-IC aims to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. The firm invests in almost all life science segments including pharmaceuticals, biotechnology, medical technology, healthcare services and industrial BioSolutions. Outside of the life sciences they invest in a diversified portfolio of equities, fixed income, real assets and alternatives. | Finance |
Forepont Capital LLC
Forepont Capital LLC Investment ManagersFinance Forepont Capital Partners invests in companies located in United States, western Europe, Singapore, Australia, and Israel. The firm focuses on sectors such as biotech, medtech, and e-health. It participates in early-stage transactions. | Finance |
